Management of Hyperglycemia in COVID-19 and Post-COVID-19 Syndrome - Proposed Guidelines for India.
J Assoc Physicians India
; 69(9): 11-12, 2021 Sep.
Article
en En
| MEDLINE
| ID: mdl-34585892
ABSTRACT
SARS-CoV-2 virus spread rapidly all over the globe in 2020 and the second wave has taken our nation, India by storm. The pandemic has posed unique challenges in people with metabolic disorders, including diabetes, hypertension, obesity, pulmonary, cardiovascular, kidney and non-alcoholic fatty liver disease. Uncontrolled diabetes, in conjunction with endocrine, inflammatory and metabolic effects of the infection itself has made management of hyperglycemia in COVID-19 infection particularly challenging. Furthermore, the post-COVID-19 syndrome has also emerged as a sequela in COVID-19 survivors, increasing the risk of death, complications and adding further burden on the health care system. With more than a year of experience, we have gained substantial insight; and now provide practical recommendations on the management of hyperglycemia in COVID-19 as well as post COVID-19 syndrome.
Search on Google
Banco de datos:
MEDLINE
Asunto principal:
COVID-19
/
Hiperglucemia
Tipo de estudio:
Etiology_studies
/
Guideline
Límite:
Humans
País como asunto:
Asia
Idioma:
En
Año:
2021
Tipo del documento:
Article